ABVC
ABVC BioPharma·NASDAQ
--
--(--)
--
--(--)
ABVC fundamentals
ABVC BioPharma (ABVC) expects to report earnings on Mar 13, 2024, with estimated revenue of 0 (YoY -100.00%), and EPS at -0.5 (YoY +66.67%).
Revenue estimate / YoY
0
-100.00%
EPS estimate / YoY
-0.5
+66.67%
Report date
Mar 13, 2024
EPS
Actual | -0.8 | -2.05 | -0.6 | -1.1 | -1.5 | -0.82 | ||||
Forecast | -0.4 | -1.25 | -2 | -1.5 | -0.5 | -0.6 | -0.4 | -0.5 | ||
Surprise | -100.00% | 0.00% | 0.00% | +52.00% | +45.00% | 0.00% | 0.00% | 0.00% | -105.00% | 0.00% |
Revenue
Actual | 31.44K | -- | 25.66K | 312.86K | 42.27K | 589.78K | -- | -- | 15.88K | -- |
Forecast | 113.26K | -- | -- | 25.92K | 26.18K | 26.44K | 0 | 300.00K | 300.00K | 0 |
Surprise | -72.24% | 0.00% | 0.00% | +1107.16% | +61.48% | +2130.82% | 0.00% | 0.00% | -94.71% | 0.00% |
Earnings Call
You can ask Aime
Did ABVC BioPharma beat or miss consensus estimates last quarter?What factors drove the changes in ABVC BioPharma's revenue and profit?What is ABVC BioPharma's gross profit margin?What is the market's earnings forecast for ABVC BioPharma next quarter?What were the key takeaways from ABVC BioPharma’s earnings call?What were the key takeaways from ABVC BioPharma's earnings call?What guidance did ABVC BioPharma's management provide for the next earnings period?What is ABVC BioPharma's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
